FDA NDC

FABIOR

This name is from the loaded FDA file.

Source: FDA NDC Directory, live from openFDA. Publisher page

NDC
51862-295
Proprietary name
FABIOR
Nonproprietary name
tazarotene
Labeler
Mayne Pharma
Dosage form
AEROSOL, FOAM
Strength
1 mg/g

Run it in Rivvi

Which 2027 plans near you dropped or restricted tazarotene?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Try it on your own data today.

Free to start. Most teams are using it the same day.